Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ElleVet hemp oil blend is a proprietary veterinary hemp extract developed by ElleVet Sciences specifically for companion animals, including dogs and cats. The formulation features a unique 50/50 ratio of cannabidiol (CBD) and cannabidiolic acid (CBDA), along with other minor cannabinoids and terpenes, delivered in an organic sesame seed oil base. The product targets the endocannabinoid system (ECS) to regulate various physiological functions such as inflammatory responses, pain perception, and neurological stability. It is primarily indicated for supporting joint mobility in cases of osteoarthritis, managing stress and anxiety, improving cognitive function in senior pets, and addressing neurological issues like seizures. The efficacy and safety of the blend have been validated through pharmacokinetic studies and clinical trials conducted in collaboration with major veterinary institutions, including Cornell University College of Veterinary Medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ElleVet hemp oil blend.